文献速递临床生化临床免疫

新冠感染后健康运动员因巨肌钙蛋白干扰出现假阳性心肌肌钙蛋白I

False-positive cardiac troponin I values due to macrotroponin in healthy athletes after COVID-19.
PubMed 文献 · Clin Chem Lab Med · 2025-06-17

该前瞻性观察研究纳入35名2022–2023年新冠感染后体检的健康运动员,用四种hs-cTn常规免疫分析法检测。18人(51%)出现cTn升高(多为cTnI),但心电图、超声心动图和CMR均无心肌炎证据;其中16人证实存在巨肌钙蛋白,IgG抗肌钙蛋白自身抗体与两种最常受影响的分析法结果显著相关。

要点

  • 新冠后健康运动员中近半数出现cTnI升高,多由巨肌钙蛋白干扰所致。
  • cTn升高但心电图、超声和CMR无心肌炎证据时应警惕分析干扰。
  • IgG抗肌钙蛋白自身抗体与Siemens Atellica和Abbott Alinity的hs-cTnI结果显著相关。

核心结论

  • 新冠感染后近半数健康运动员因巨肌钙蛋白干扰出现cTnI假阳性升高。
  • 认识这一分析干扰可避免对假阳性cTnI运动员进行不必要的侵入性或昂贵检查。

研究设计与样本

  • 前瞻性观察研究,纳入35名2022–2023年新冠后体检的健康运动员(16–75岁;19女、16男)。
  • 用四种hs-cTn常规免疫分析法检测cTn,分析间不一致时用蛋白G柱、蔗糖梯度超速离心和抗肌钙蛋白自身抗体免疫分析进一步检测巨肌钙蛋白。

主要发现

  • cTn升高者心电图、超声心动图和CMR均无心肌炎或其他心脏异常。
  • 18名cTn升高者中16名证实存在巨肌钙蛋白。
  • IgG抗肌钙蛋白自身抗体与hs-cTnI-Siemens Atellica和hs-cTnI-Abbott Alinity两种最常受影响分析法的结果显著相关。

关键数值与推荐

  • 18名(51%)运动员cTn升高,其中16名证实巨肌钙蛋白。
  • 巨肌钙蛋白检测采用蛋白G柱、蔗糖梯度超速离心和抗肌钙蛋白自身抗体免疫分析。

临床怎么用

  • 新冠后运动员cTnI升高而心脏影像无异常时,应考虑巨肌钙蛋白干扰并及时与检验科沟通。
  • 不同hs-cTn分析法间结果不一致可提示分析干扰,必要时加做巨肌钙蛋白检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cardiac troponins (cTn) are used to detect and quantify acute cardiomyocyte injury. In patients presenting with symptoms that could indicate myocarditis, elevated cTn concentrations typically mandate cardiac catheterization and heart muscle biopsy or cardiac magnetic resonance imaging (CMR). Accordingly, increased cTn levels due to macrotroponin - a complex between patient anti-troponin autoantibodies and cTn - could lead to unnecessary and potentially harmful interventions. In athletes, ensuring cardiac health after infection like COVID-19 is critical, but the occurrence of false-positive cTn levels post-COVID-19 remains unknown. METHODS: This observational study prospectively included 35 healthy athletes (aged 16-75 years; 19 females, 16 males) who underwent post-COVID check-ups during 2022-2023. Athletes' cTn levels were measured using four different hs-cTn routine immunoassays. If discrepancies were noted between assays, further testing for macrotroponin was conducted using protein G column, sucrose gradient ultracentrifugation and anti-troponin autoantibody immunoassay. RESULTS: Seventeen athletes had normal cTn levels across all assays, while 18 (51 %) had elevated cTn, mostly cTnI. Despite elevated cTn levels, no signs of myocarditis or other cardiac conditions were found on electrocardiography, echocardiography, or CMR. Macrotroponin was confirmed among 16 of these 18 athletes. Further, IgG anti-troponin autoantibodies correlated significantly with the levels of the two most-commonly affected assays: hs-cTnI-Siemens Atellica and hs-cTnI-Abbott Alinity. CONCLUSIONS: Post-COVID-19, nearly half of athletes showed elevated cTnI levels due to interference from macrotroponin. Awareness among physicians and laboratorians of this analytical confounder can avoid unnecessary invasive or costly diagnostic tests in athletes with false-positive cTnI levels after COVID-19.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Hammerer-Lercher A, Kissel CK, Wittfooth S, et al. False-positive cardiac troponin I values due to macrotroponin in healthy athletes after COVID-19. Clin Chem Lab Med. 2025. PMID: 40853145. doi:10.1515/cclm-2025-0427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。